直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Prince M. Ene, Pharm. D.
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4036
prince.ene@finnegan.com prince.ene@finnegan.com

Prince M. Ene, Pharm. D.

Associate

  • +1 202 408 4036 +1 202 408 4036
  • prince.ene@finnegan.com prince.ene@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Prince Ene, Pharm.D., combines a strong foundation in pharmaceutical sciences with legal training to support clients in complex patent litigation matters within the life sciences and  chemical industries. Holding a Doctor of Pharmacy and a bachelor’s degree in health sciences with a focus in biochemistry, Prince demonstrates both scientific fluency and deep insight into matters involving drug development, intellectual property (IP) strategy, and Food and Drug Administration (FDA) regulatory overlap. 

Prince contributes to the development of IP strategies for pharmaceutical and biotechnology clients. He draws on his clinical and research-based studies to assess technical issues in patent disputes, particularly those related to active pharmaceutical ingredients and methods of treatment. Prince has supported and collaborated with cross-functional teams to ensure alignment between research and development (R&D) and IP protection.

 

Prior to joining the firm, Prince completed an IP internship at a global pharmaceutical company, where he assisted in patent strategy and freedom-to-operate (FTO) analyses for early- and late-stage chemical compounds. He gained further clinical and academic experience through advanced pharmacy practice rotations in medication safety, academia, and therapy management.  Prince served as a teaching assistant in pharmacotherapeutics and medicinal chemistry. He has held leadership roles in student organizations focused on cultural competence and IP law.

 

Insights

At the PTAB Blog

Tesla’s Preservation of District Court Indefiniteness Positions Creates IPR Roadblock Tesla’s Preservation of District Court Indefiniteness Positions Creates IPR Roadblock

November 18, 2025

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – November 2025 Spotlight on Upcoming Oral Arguments – November 2025

November 4, 2025

Federal Circuit IP Blog

Federal Circuit Clarifies Prosecution History Disclaimer in Design Patents and Reverses Finding of Design Patent and Trademark Infringement Federal Circuit Clarifies Prosecution History Disclaimer in Design Patents and Reverses Finding of Design Patent and Trademark Infringement

October 27, 2025

Federal Circuit IP Blog

Federal Circuit Reverses $106M Verdict, Finding Doctrine of Equivalents Barred by Prosecution History Estoppel Federal Circuit Reverses $106M Verdict, Finding Doctrine of Equivalents Barred by Prosecution History Estoppel

October 22, 2025

Federal Circuit IP Blog

Federal Circuit Affirms PTAB’s Obviousness Analysis for Recessed Lighting Patent Federal Circuit Affirms PTAB’s Obviousness Analysis for Recessed Lighting Patent

April 29, 2025

Federal Circuit IP Blog

Federal Circuit Upholds Partial Cancellation of MONEY MART Registrations in Brittex v. Dollar Financial Federal Circuit Upholds Partial Cancellation of MONEY MART Registrations in Brittex v. Dollar Financial

April 29, 2025

More

News

Press Release

BMW AG Announces Resolution of WDTX Declaratory Judgment against Onesta, Following Broad Covenant Not to Sue to BMW AG by Onesta BMW AG Announces Resolution of WDTX Declaratory Judgment against Onesta, Following Broad Covenant Not to Sue to BMW AG by Onesta

April 23, 2026

Press Release

Judge Albright Issues Ex Parte TRO Blocking Foreign Efforts to Interfere with U.S. Patent Jurisdiction in BMW Case Judge Albright Issues Ex Parte TRO Blocking Foreign Efforts to Interfere with U.S. Patent Jurisdiction in BMW Case

December 17, 2025

Press Release

Action Filed to Prevent Foreign Courts from Deciding U.S. Patent Claims Action Filed to Prevent Foreign Courts from Deciding U.S. Patent Claims

December 15, 2025

Media Mention

BMW Texas Suit Accuses Patent Owner of Forum Shopping in Germany BMW Texas Suit Accuses Patent Owner of Forum Shopping in Germany

December 15, 2025

Bloomberg Law

Professional Activities

  • American Intellectual Property Law Association (AIPLA)
  • Houston Intellectual Property Law Association (HIPLA)
Admissions and Education

Admissions

  • Texas

Admitted in Texas only; practicing under the supervision of the partners of the Washington, D.C. office of Finnegan.

Education

Texas Southern University, Thurgood Marshall School of Law
J.D.,

cum laude, 2025

Howard University College of Pharmacy
Pharm. D., 2022
University of Central Arkansas
B.S., Health Science, 2017

Prince's Practices

Diligence, Licensing, and Opinions
Freedom to Operate Opinions
Opinions and Counseling
Global IP Enforcement, Litigation, and Trials
Branded Hatch-Waxman (ANDA) Litigation and Trials
Patent Litigation and Trials
Prosecution and Portfolio Management
Patent Drafting and Prosecution

Prince's Industries

Chemicals, Industrials, and Materials
Chemical
Life Sciences
Biologics
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP